Easy, fast, convenient Great product
Sources: Neelakantan et al., Biochem Pharmacol 2018 | Dimet-Wiley et al., Sci Rep 2024 Security Profile & Chemical Identity Molecular specifications and preclinical safety data 5-Amino-1MQ Chemical Identity A small molecule derived from quinolinium salts, developed at the University of Texas (2017) 5-Amino-1MQ Tolerance & Status Safety data from preclinical studies (DIO mouse model) Published Preclinical Data 3 key studies published in Biochemical Pharmacology and Scientific Reports 35% Reduction of white adipose tissue in 11 days (20 mg/kg, 3 times/day) Physical Effects (11 days) + 40 % Improvement of grip strength in aged mice (22-24 months) Strength & Performance (aged mice) microbiome The combination of 5-Amino-1MQ + caloric restriction establishes a distinct gut microbial profile Protocol & Results Important Notice Search Only Not intended for human consumption

Description 5-Amino-1MQ 5 mg 5-Amino-1MQ is a small molecule investigated for its ability to inhibit nicotinamide N-methyltransferase (NNMT), an enzyme closely linked to cellular metabolism and energy regulation. Research suggests that blocking NNMT activity may influence NAD+ metabolism, fat cell function, and metabolic balance
Sedation or anesthesia is not included in CPT 62321 and may be billed separately if medically necessary and properly documented, depending on payer guidelines
5-Amino-1MQ represents a new frontier in peptide therapy, offering unique benefits for fat loss, metabolic health, and energy